Johns Hopkins ABX Guide
Baloxavir
Baloxavir is a topic covered in the Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Treatment of uncomplicated influenza, ages ≥ 12 years with symptoms < 48 hours.
- Limitations of use: Consideration should be given to susceptibility patterns for circulating influenza virus strains when deciding whether to use baloxavir because viruses’ changing over time, virus type or subtype, the emergence of resistance, or changes in viral virulence could diminish the clinical benefit of antiviral drugs.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of influenza in individuals at high risk for influenza-related complications
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
FDA
FDA
- Treatment of uncomplicated influenza, ages ≥ 12 years with symptoms < 48 hours.
- Limitations of use: Consideration should be given to susceptibility patterns for circulating influenza virus strains when deciding whether to use baloxavir because viruses’ changing over time, virus type or subtype, the emergence of resistance, or changes in viral virulence could diminish the clinical benefit of antiviral drugs.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Treatment of influenza in individuals at high risk for influenza-related complications
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 15, 2022
Citation
Dzintars, Kate, and Edina Avdic. "Baloxavir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2022. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540707/all/Baloxavir.
Dzintars K, Avdic E. Baloxavir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540707/all/Baloxavir. Accessed March 30, 2023.
Dzintars, K., & Avdic, E. (2022). Baloxavir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540707/all/Baloxavir
Dzintars K, Avdic E. Baloxavir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2022. [cited 2023 March 30]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540707/all/Baloxavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Baloxavir
ID - 540707
A1 - Dzintars,Kate,Pharm.D., BCPS
AU - Avdic,Edina,Pharm.D.
Y1 - 2022/10/15/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540707/all/Baloxavir
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
